Casdin Capital, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$122,472,203
+5.4%
1,010,330
-0.5%
13.56%
+33.4%
Q2 2023$116,237,800
-28.8%
1,015,000
-14.3%
10.16%
-24.5%
Q1 2023$163,328,550
-4.1%
1,185,000
-9.9%
13.45%
+1.9%
Q4 2022$170,397,700
+25.8%
1,315,000
+7.3%
13.20%
+48.4%
Q3 2022$135,412,000
+177.9%
1,225,000
+88.5%
8.90%
+115.9%
Q2 2022$48,724,000
-22.0%
650,000
-18.8%
4.12%
+47.0%
Q1 2022$62,496,000
-48.6%
800,000
-40.7%
2.80%
-18.2%
Q4 2021$121,568,000
+19.5%
1,350,000
+22.7%
3.43%
+35.3%
Q3 2021$101,728,000
+47.9%
1,100,000
+24.3%
2.53%
+45.0%
Q2 2021$68,800,000
+67.8%
885,000
+60.9%
1.75%
+43.0%
Q1 2021$40,992,000
-54.6%
550,000
+3.8%
1.22%
-54.4%
Q4 2020$90,360,000
+21.4%
530,0000.0%2.68%
-19.7%
Q3 2020$74,428,000
-12.4%
530,0000.0%3.33%
-33.7%
Q2 2020$84,980,000
+29.7%
530,000
-20.9%
5.03%
-27.7%
Q1 2020$65,539,000
-24.2%
670,0000.0%6.96%
-12.5%
Q4 2019$86,457,000
-99.9%
670,000
-23.9%
7.95%
+15.9%
Q3 2019$66,281,600,000
+30.2%
880,000
+162.7%
6.86%
+43.9%
Q2 2019$50,903,250,000
+139924.9%
335,000
+9.8%
4.76%
+19.3%
Q1 2019$36,353,000
+122.1%
305,000
+103.3%
3.99%
+42.6%
Q4 2018$16,370,000
+153.4%
150,000
+275.0%
2.80%
+256.8%
Q3 2018$6,460,00040,0000.78%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders